Literature DB >> 12952183

Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation.

Renny T Franceschi1, Guozhi Xiao, Di Jiang, Rajaram Gopalakrishnan, Shuying Yang, Elizabeth Reith.   

Abstract

The Cbfa1/Runx2 transcription factor is essential for osteoblast differentiation. However, levels of Runx2 are often not well correlated with its transcriptional activity suggesting that this factor must be activated either by covalent modification or through interactions with other nuclear components. Runx2 is phosphorylated and activated by the mitogen-activated protein kinase (MAPK) pathway. This pathway is stimulated in at least two ways: by binding of type I collagen to alpha2beta1 integrins on the osteoblast surface and by treatment of cells with the osteogenic growth factor, FGF2. Protein kinase A (PKA) also may phosphorylate/activate Runx2 under certain conditions. Runx2 activity also is enhanced by factors known to stimulate specific signal transduction pathways such as PTH/PTHrP (signals through PKA and PKC pathways) and BMPs (Signal through Smad proteins). Interactions with Runx2 are complex involving both binding of distinct components such as AP-1 factors and Smads to separate sites on DNA, direct interactions between Runx2 and AP-1/Smad factors and MAPK or PKA-dependent Runx2 phosphorylation. These findings suggest that Runx2 plays a central role in coordinating multiple signals involved in osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952183      PMCID: PMC3564252     

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  33 in total

Review 1.  The role of transcription factors involved in TGFbeta superfamily signaling during development.

Authors:  M Watanabe; M Whitman
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1999-07       Impact factor: 1.770

Review 2.  Fibroblast growth factor-2.

Authors:  M A Nugent; R V Iozzo
Journal:  Int J Biochem Cell Biol       Date:  2000-02       Impact factor: 5.085

3.  Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter.

Authors:  J Hanai; L F Chen; T Kanno; N Ohtani-Fujita; W Y Kim; W H Guo; T Imamura; Y Ishidou; M Fukuchi; M J Shi; J Stavnezer; M Kawabata; K Miyazono; Y Ito
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

4.  MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1.

Authors:  G Xiao; D Jiang; P Thomas; M D Benson; K Guan; G Karsenty; R T Franceschi
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

5.  Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1.

Authors:  N Selvamurugan; M R Pulumati; D R Tyson; N C Partridge
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

6.  Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.

Authors:  D Zimmerman; F Jin; P Leboy; S Hardy; C Damsky
Journal:  Dev Biol       Date:  2000-04-01       Impact factor: 3.582

Review 7.  The osteoblast: a sophisticated fibroblast under central surveillance.

Authors:  P Ducy; T Schinke; G Karsenty
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures.

Authors:  Y X Zhou; X Xu; L Chen; C Li; S G Brodie; C X Deng
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

Review 9.  The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment.

Authors:  R T Franceschi
Journal:  Crit Rev Oral Biol Med       Date:  1999

Review 10.  FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models.

Authors:  K Kannan; D Givol
Journal:  IUBMB Life       Date:  2000-03       Impact factor: 3.885

View more
  75 in total

1.  The human T locus and spina bifida risk.

Authors:  Liselotte E Jensen; Sandrine Barbaux; Katy Hoess; Sven Fraterman; Alexander S Whitehead; Laura E Mitchell
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

Review 2.  Cellular and molecular mechanisms of bone remodeling.

Authors:  Liza J Raggatt; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 3.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

4.  Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

Authors:  Yong Sun; Chang Hyun Byon; Kaiyu Yuan; Jianfeng Chen; Xia Mao; Jack M Heath; Amjad Javed; Kui Zhang; Peter G Anderson; Yabing Chen
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

5.  Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals.

Authors:  Laura L Hernandez; Karen A Gregerson; Nelson D Horseman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

6.  Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation.

Authors:  Nagarajan Selvamurugan; Emi Shimizu; Minnkyong Lee; Tong Liu; Hong Li; Nicola C Partridge
Journal:  FEBS Lett       Date:  2009-03-03       Impact factor: 4.124

7.  FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.

Authors:  Ok-Jin Park; Hyun-Jung Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

8.  IL-7 suppresses osteogenic differentiation of periodontal ligament stem cells through inactivation of mitogen-activated protein kinase pathway.

Authors:  Cong-Xiang Jian; Quan-Shui Fan; Yong-He Hu; Yong He; Ming-Zhe Li; Wei-Yin Zheng; Yu Ren; Chen-Jun Li
Journal:  Organogenesis       Date:  2016-08-31       Impact factor: 2.500

9.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

10.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.